The definitive exact-match pair: MedicalCordBlood.com + CordBlood.us. A proven, high-comparable category. Contact us for exclusive bundle pricing!
The cord blood banking market is $4.2B in 2025, projected to reach $7-9B by 2030 (12-15% CAGR). These 2 exact-match domains provide complete category coverage—medical professionals use "medical cord blood" while U.S. families search "cord blood."
Category-defining anchor asset
THE category-defining domain for cord blood banking. "Medical cord blood" is the professional, authoritative term used by OB/GYNs, hospitals, and medical literature. Perfect for private cord blood banks, public cord blood registries, medical information portals, or hospital cord blood donation programs. Positions as medical-grade, clinical service.
Use Cases
Private cord blood bank (Cryo-Cell model), public cord blood registry, hospital donation program portal, medical education platform, stem cell research institute
Natural Buyers
Cryo-Cell ($100M+ revenue), ViaCord (acquired by PerkinElmer), CBR (Cord Blood Registry), FamilyCord, Americord, Lifebank, Maze Cord Blood
Revenue Model
Private banking: $1,500-2,500 enrollment + $150-300/year storage = $150M+ potential revenue with 50K clients. Affiliate: Refer clients to cord blood banks for $200-500 per enrollment. B2B: License domain to hospital networks for donation programs.
U.S. market companion name
"Cord blood" is THE consumer term. Parents Google "cord blood banking" before delivery. CordBlood.us captures U.S. market specifically—crucial since cord blood banking regulations vary by country. Perfect for U.S.-focused cord blood bank, comparison site, or educational portal targeting American families.
Why .us Extension Works: Cord blood regulations are country-specific. U.S. families want U.S.-based banks (FDA oversight, domestic storage). CordBlood.us signals "U.S. market authority" better than generic .net or .org alternatives.
Comparable Sales: The .com equivalent in this niche trades at a very high premium. CordBlood.us delivers the same brand in a different TLD at a fraction of the cost.
Medical Breakthrough: Cord blood stem cells treat 80+ diseases (leukemia, lymphoma, sickle cell, cerebral palsy). FDA-approved treatments = credibility.
Insurance Coverage Expanding: Some states mandate insurance cover cord blood for high-risk pregnancies. Medicaid reimbursement in select cases.
Celebrity Endorsement: Kim Kardashian, Serena Williams publicly stored cord blood. Mainstream = mass adoption.
Public + Private Model: Can donate to public registry (free) OR bank privately ($2K). Both need marketing = domain demand.
Major Private Banks: Cryo-Cell ($100M+ revenue), CBR (acquired by AMAG for $700M), ViaCord (PerkinElmer subsidiary), FamilyCord, Americord (Series B $30M funding).
Public Registries: National Marrow Donor Program, Be The Match, state-funded cord blood banks need public awareness domains.
Hospital Networks: Kaiser, HCA Healthcare, Mayo Clinic offer cord blood donation—need consumer-facing portals.
International Expansion: Asian cord blood banks (China Cord Blood Corp $2B valuation) entering U.S. market need authoritative domains.
You own BOTH angles: MedicalCordBlood.com = professional/clinical authority (doctors, hospitals, research). CordBlood.us = consumer-facing U.S. market leader (expectant parents, comparison shoppers). Competitors can't outrank you on either front. Complete category lockout.
Comparable Domain Sales: Category .com domains in this space command six-figure prices. You're getting MedicalCordBlood.com (more descriptive, medically authoritative) + CordBlood.us as a bundle — contact us for exclusive pricing.
Why Now: CBR sold for $700M to AMAG Pharmaceuticals. Americord raised $30M Series B. Cryo-Cell trades publicly ($100M+ market cap). Major acquisitions = strategic buyers actively seeking domains to expand market share. These domains never come available again.